{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:42:42Z","timestamp":1760132562459,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13643-018-0923-2","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T03:04:25Z","timestamp":1545879865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Using tocolysis in pregnant women with symptomatic placenta praevia does not significantly improve prenatal, perinatal, neonatal and maternal outcomes: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7520-082X","authenticated-orcid":false,"given":"Frederick","family":"Morfaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercy","family":"Fundoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bartoszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Mbuagbaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,27]]},"reference":[{"issue":"1","key":"923_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-0030-1262510","volume":"28","author":"DA Bose","year":"2011","unstructured":"Bose DA, Assel BG, Hill JB, Chauhan SP. Maintenance tocolytics for preterm symptomatic placenta previa: a review. Am J Perinatol. 2011;28(1):45\u201350.","journal-title":"Am J Perinatol"},{"key":"923_CR2","first-page":"CD001998","volume":"2","author":"JP Neilson","year":"2000","unstructured":"Neilson JP. Interventions for suspected placenta praevia. Cochrane Database Syst Rev. 2000;2:CD001998.","journal-title":"Cochrane Database Syst Rev"},{"key":"923_CR3","first-page":"CD001998","volume":"2","author":"JP Neilson","year":"2003","unstructured":"Neilson JP. Interventions for suspected placenta praevia. Cochrane Database Syst Rev. 2003;2:CD001998.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"923_CR4","doi-asserted-by":"publisher","first-page":"e0173717","DOI":"10.1371\/journal.pone.0173717","volume":"12","author":"E Verspyck","year":"2017","unstructured":"Verspyck E, de Vienne C, Muszynski C, Bubenheim M, Chanavaz-Lacheray I, Dreyfus M, et al. Maintenance nifedipine therapy for preterm symptomatic placenta previa: a randomized, multicenter, double-blind, placebo-controlled trial. PLoS One. 2017;12(3):e0173717.","journal-title":"PLoS One"},{"issue":"5","key":"923_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1067\/mob.2003.76","volume":"188","author":"CV Ananth","year":"2003","unstructured":"Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta previa on neonatal mortality: a population-based study in the United States, 1989 through 1997. Am J Obstet Gynecol. 2003;188(5):1299\u2013304.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"923_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1067\/mob.2003.303","volume":"188","author":"HM Salihu","year":"2003","unstructured":"Salihu HM, Li Q, Rouse DJ, Alexander GR. Placenta previa: neonatal death after live births in the United States. Am J Obstet Gynecol. 2003;188(5):1305\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"923_CR7","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0002-9378(11)90776-5","volume":"168","author":"S Iyasu","year":"1993","unstructured":"Iyasu S, Saftlas AK, Rowley DL, Koonin LM, Lawson HW, Atrash HK. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol. 1993;168(5):1424\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"923_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/941057","volume":"2011","author":"C Hubinont","year":"2011","unstructured":"Hubinont C, Debieve F. Prevention of preterm labour: 2011 update on tocolysis. J Pregnancy. 2011;2011:1\u20135.","journal-title":"J Pregnancy"},{"key":"923_CR9","first-page":"1089","volume":"76","author":"RB Newman","year":"1990","unstructured":"Newman RB, Campbell BASS. Objective tocodynamometry identifies labor onset earlier than subjective maternal perception. Obstet Gynecol. 1990;76:1089\u201392.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"923_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1479-828X.1993.tb02045.x","volume":"33","author":"EF Magann","year":"1993","unstructured":"Magann EF, Johnson CA, Gookin KS, Roberts WE, Martin RW, Morrison JC. Placenta praevia: does uterine activity cause bleeding? Aust N Z J Obstet Gynaecol. 1993;33(1):22\u20134.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"923_CR11","first-page":"176","volume":"65","author":"PM McShane","year":"1985","unstructured":"McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol. 1985;65(2):176\u201382.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"923_CR12","first-page":"745","volume":"30","author":"PG Tomich","year":"1985","unstructured":"Tomich PG. Prolonged use of tocolytic agents in the expectant management of placenta previa. J Reprod Med. 1985;30(10):745\u20138.","journal-title":"J Reprod Med"},{"issue":"2","key":"923_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0020-7292(03)00198-X","volume":"84","author":"A Sharma","year":"2004","unstructured":"Sharma A, Suri V, Gupta I. Tocolytic therapy in conservative management of symptomatic placenta previa. Int J Gynaecol Obstet. 2004;84(2):109\u201313.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"923_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.semcdb.2007.05.002","volume":"18","author":"AL Bernal","year":"2007","unstructured":"Bernal AL. The regulation of uterine relaxation. Semin Cell Dev Biol. 2007;18(3):340\u20137.","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"923_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1056\/NEJMra050435","volume":"357","author":"HN Simhan","year":"2007","unstructured":"Simhan HN, Caritis SN. Prevention of preterm delivery. N Engl J Med. 2007;357(6):477\u201387.","journal-title":"N Engl J Med"},{"issue":"6 Pt 1","key":"923_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0002-9378(99)70053-0","volume":"180","author":"CV Towers","year":"1999","unstructured":"Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol. 1999;180(6 Pt 1):1572\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"923_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9378(84)80102-7","volume":"150","author":"R Silver","year":"1984","unstructured":"Silver R, Depp R, Sabbagha RE, Dooley SL, Socol ML, Tamura RK. Placenta previa: aggressive expectant management. Am J Obstet Gynecol. 1984;150(1):15\u201322.","journal-title":"Am J Obstet Gynecol"},{"key":"923_CR18","volume-title":"Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. Green-top Guideline No. 27","author":"Royal College of Obstetricians and Gynecologists","year":"2011","unstructured":"Royal College of Obstetricians and Gynecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. Green-top Guideline No. 27. 3rd ed. London: Royal College of Obstetricians and Gynecologists; 2011.","edition":"3"},{"issue":"6","key":"923_CR19","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/0002-9378(95)91410-2","volume":"172","author":"RE Besinger","year":"1995","unstructured":"Besinger RE, Moniak CW, Paskiewicz LS, Fisher SG, Tomich PG. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol. 1995;172(6):1770\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"923_CR20","first-page":"692","volume":"99","author":"JS Dashe","year":"2002","unstructured":"Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol. 2002;99(5 Pt 1):692\u20137.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"923_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2288-12-31","volume":"12","author":"S Ross","year":"2012","unstructured":"Ross S, Milne J, Dwinnell S, Tang S, Wood S. Is it possible to estimate the minimal clinically important treatment effect needed to change practice in preterm birth prevention? Results of an obstetrician survey used to support the design of a trial. BMC Med Res Methodol. 2012;12(1):31.","journal-title":"BMC Med Res Methodol"},{"key":"923_CR22","unstructured":"Higgins JPT, Altman DG, Sterne JA. Assessing risk of bias in included studies. In: JPT H, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 510 Updated March 2011 [Internet]. Chichester: The Cochrane Collaboration; 2011. p. 2011. Available from: \n                    http:\/\/handbook.cochrane.org\n                    \n                  ."},{"key":"923_CR23","unstructured":"The Nordic Cochrane Centre TCC. Review Manager (RevMan) [Computer program]. Version 5.3. Copenhagen: The Cochrane Collaboration; 2014."},{"issue":"1","key":"923_CR24","first-page":"8","volume":"9","author":"GH Guyatt","year":"2009","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Chinese J Evidence-Based Med. 2009;9(1):8\u201311.","journal-title":"Chinese J Evidence-Based Med"},{"key":"923_CR25","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from \n                    gradepro.org\n                    \n                  ."},{"issue":"12","key":"923_CR26","first-page":"754","volume":"56","author":"L Sozanski","year":"1985","unstructured":"Sozanski L, Gerber J. Effect of partusisten administered to pregnant women with uterine hemorrhage caused by placenta praevia on the prolongation of pregnancy. Ginekol Pol. 1985;56(12):754\u20138.","journal-title":"Ginekol Pol"},{"key":"923_CR27","first-page":"CD006169","volume":"7","author":"JP Vogel","year":"2014","unstructured":"Vogel JP, Nardin JM, Dowswell T, West HM, Oladapo OT. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;7:CD006169.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"923_CR28","first-page":"125","volume":"10","author":"DN Saller Jr","year":"1990","unstructured":"Saller DN Jr, Nagey D, Pupkin MJ, Crenshaw MCJ. Tocolysis in the management of third trimester bleeding. J Perinatol. 1990;10(2):125\u20138.","journal-title":"J Perinatol"},{"issue":"6","key":"923_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0002-9378(15)33242-7","volume":"137","author":"DB Cotton","year":"1980","unstructured":"Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. Am J Obstet Gynecol. 1980;137(6):687\u201395.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"923_CR30","first-page":"176","volume":"65","author":"PM McShane","year":"1985","unstructured":"McShane PM, Heyl PS. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol. 1985;65(2):176\u201382.","journal-title":"Obstet Gynecol"},{"key":"923_CR31","first-page":"1","volume":"27","author":"Royal College of Obstetricians and Gynaecologists (RCOG)","year":"2011","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG). Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management - Green-top Guideline. R Coll Obstet Gynaecol. 2011;27:1\u201326.","journal-title":"R Coll Obstet Gynaecol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13643-018-0923-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T19:25:19Z","timestamp":1577388319000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-018-0923-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1186\/s13643-018-0923-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Being a systematic review of published literature, we did not need any ethical approval nor patient consent in order to conduct this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"249"}}